Lewis F. Neville
Amministratore Delegato presso Lostam BioPharmaceuticals Ltd.
Posizioni attive di Lewis F. Neville
Società | Posizione | Inizio | Fine |
---|---|---|---|
Lostam BioPharmaceuticals Ltd.
Lostam BioPharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lostam BioPharmaceuticals Ltd. engages in the development of protein therapeutics aimed to prevent and treat lethal Gram-negative bacterial infections associated within the hospital setting. The company was founded by Lewis F. Neville on October 15, 2009 and is headquartered in Nof HaGalil, Israel. | Amministratore Delegato | 15/10/2009 | - |
Direttore Tecnico/Scientifico/R&S | 15/10/2009 | - | |
Fondatore | 15/10/2009 | - |
Storia della carriera di Lewis F. Neville
Precedenti posizioni note di Lewis F. Neville
Società | Posizione | Inizio | Fine |
---|---|---|---|
XTL BIOPHARMACEUTICALS LTD. | Corporate Officer/Principal | 01/01/2003 | 01/01/2003 |
Zolex Therapeutics Ltd.
Zolex Therapeutics Ltd. BiotechnologyHealth Technology Zolex Therapeutics Ltd. operates as a biotechnology company. It develops orally active, small molecular weight antibioticsthat target straphylococcus aureus. The company is headquartered in Tel Aviv, Israel. | Direttore Tecnico/Scientifico/R&S | - | - |
Fondatore | - | - | |
Sidney Kimmel Medical College | Corporate Officer/Principal | 01/01/1992 | - |
Formazione di Lewis F. Neville
University of Leeds | Undergraduate Degree |
The University of Southampton | Doctorate Degree |
Statistiche
Distribuzione geografica
Israele | 4 |
Regno Unito | 3 |
Stati Uniti | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 4 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
XTL BIOPHARMACEUTICALS LTD. | Health Technology |
Aziende private | 2 |
---|---|
Lostam BioPharmaceuticals Ltd.
Lostam BioPharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lostam BioPharmaceuticals Ltd. engages in the development of protein therapeutics aimed to prevent and treat lethal Gram-negative bacterial infections associated within the hospital setting. The company was founded by Lewis F. Neville on October 15, 2009 and is headquartered in Nof HaGalil, Israel. | Health Technology |
Zolex Therapeutics Ltd.
Zolex Therapeutics Ltd. BiotechnologyHealth Technology Zolex Therapeutics Ltd. operates as a biotechnology company. It develops orally active, small molecular weight antibioticsthat target straphylococcus aureus. The company is headquartered in Tel Aviv, Israel. | Health Technology |
- Borsa valori
- Insiders
- Lewis F. Neville
- Esperienza